Abstract
There is now an increasing body of evidence which strongly suggests that excess production of nitric oxide (NO) is responsible for the severe hypotension commonly seen in septic shock. Very recently, Gomez-Jimenez et al. [1] have shown that plasma nitrite and nitrate levels were not different between a control group of patients and those with sepsis, but the values in both these groups were significantly lower than in a group of patients with septic shock. In addition, they were able to show a correlation between nitrite and nitrate levels and cardiac output and plasma endotoxin levels in the septic group.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gómez-Jiménez J, Salgado A, Mourelle M, et al (1995) L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253–258
Cobb JP, Cunnion RE, Danner RL (1993) Nitric oxide as a target for therapy in septic shock. Crit Care Med 21:1261–1263
Cobb JP, Natanson C, Hoffman WD, et al (1992) N-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality in canines challenged with endotoxin. J Exp Med 176:1175–1182
Biliar TR, Curran RD, Harbrecht BG, et al (1990) Modulation of nitrogen oxide synthesis in vivo: N mono-methyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48:565–569
Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibition on hypotension in patients with septic shock. Lancet 338:1557–1558
Lorente JA, LandÃn L, De Pablo R, et al (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21:1287–1285
Petros A, Lamb, Leone A, et al (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34–39
Preiser JC, Lejeune P, Roman A, et al (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23:259–264
Brüssel T, Meyer J (1995) Nitric oxide synthesis inhibition in septic shock. Crit Care Med 23:412 (Letter)
Cobb JP, Cunnion RE, Danner RL (1995) Nitric oxide synthesis inhibition in septic shock. Crit Care Med 23:413–414 (Letter)
Lorente J A Landin, Renes E, Liste D (1995) Nitric oxide synthesis inhibition in septic shock. Crit Care Med 23:414–415 (Letter)
Yu M, Tomasa G (1993) A double blind, prospective, randomized trial ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of adult respiratory distress syndrome. Crit Care Med 21:1635–1642
Bogle RG, Whitley GS, Soo SC, et al (1994) Effect of anti-fungal imidazoles on mRNA levels and enzyme activity of inducible nitric oxide synthase. Br J Pharmacol 111: 1257–1261
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bennett, E.D. (1995). Inhibition of Nitric Oxide Production in Clinical Septic Shock. In: Fink, M.P., Payen, D. (eds) Role of Nitric Oxide in Sepsis and ADRS. Update in Intensive Care and Emergency Medicine, vol 24. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79920-4_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-79920-4_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79922-8
Online ISBN: 978-3-642-79920-4
eBook Packages: Springer Book Archive